Biomedical subjects
Publications and source records attributed to Keigo Endo.
For the detection of sentinel lymph nodes, the technetium-99m (99mTc) method is the most accurate and widely used. 99mTc has many advantages, such as a short half-life of 6 h, emission of 140 KeV gamma-rays, etc. Radiation to medical personnel is minimal and this technique can be safely performed under the guidelines issued by the Japanese Society of Nuclear Medicine.
BACKGROUND: The role and potential value of positron emission tomography (PET) scanning in certain tumors has been widely investigated in recent years. The authors retrospectively assessed the performance of 18-F-fluorodeoxyglucose (FDG)-PET in the assessment of esophageal squamous cell carcinoma (SCC). METHODS: The results using PET were compared with those using computed tomography (CT), and these were correlated with the pathologic findings. The authors studied 32 patients with thoracic esophageal SCC who had undergone radical esophagectomy. RESULTS: Uptake of FDG in the primary tumor was found in 25 of the 32 (78.1%) cases. Comparison of the FDG uptake and the clinicopathologic findings showed that there was a significant association between the FDG uptake and each of the depth of tumor invasion (P < 0.05), occurrence of lymph node metastasis (P < 0.01), and lymphatic invasion (P < 0.01). The survival rate in cases with high FDG uptake (standardized uptake value [SUV], >3) was significantly lower than that in cases with low FDG uptake (SUV, < 3; P < 0.05). In the evaluation of lymph node staging by the detection of lymph node metastasis, FDG-PET showed 77.8% sensitivity, 92.9% specificity, and 84.4% accuracy, and CT scanning showed 61.1% sensitivity, 71.4% specificity, and 65.6% accuracy. Positron emission tomography scanning showed a high degree of accuracy in the neck, upper thoracic, and abdominal regions. However, in the mid- and lower thoracic regions, the sensitivity was very low. The smallest lymph node metastasis that was detected by FDG-PET imaging was 6 mm. The average size of lymph node metastasis that was undetected by FDG-PET scanning was 7.3 mm (range, 1-17 mm). CONCLUSIONS: In conclusion, FDG-PET may be used as a noninvasive diagnostic technique in assessing the aggressiveness of the tumor and the prognosis in patients with esophageal SCC. During the preoperative diagnostic procedures, the sensitivity, specificity, and accuracy of lymph node staging is higher with FDG-PET than with CT imaging. In view of the high specificity of FDG-PET, it also gives useful information to guide the choice of treatment of esophageal carcinoma.
PURPOSE: To determine whether the centric reordered snapshot fast low-angle shot (reordered turboFLASH) magnetic resonance (MR) images with no, low, and high motion-probing gradients (MPGs) were useful to evaluate hepatic lesions and hepatic parenchyma. MATERIALS AND METHODS: The measured diffusion coefficient (D), deviation factor (f), and apparent diffusion coefficient for flowing spin (D*) values for 92 hepatic lesions (33 hepatocellular carcinomas (HCCs), 17 metastases, 27 hemangiomas, and 15 cysts) and the nonlesion-bearing regions of parenchyma in 74 livers (46 noncirrhotic and 28 cirrhotic) were approximately calculated from the reordered turboFLASH images (modified for diffusion sensitivities of b = 0, 50.2, and 295 seconds/mm(2)). RESULTS: These groups, listed in order of decreasing D* and f values, were cysts, noncirrhotic livers, cirrhotic livers, hemangiomas, metastases, and HCCs. The order on the basis of D values was cysts, hemangiomas, metastases, HCCs, cirrhotic livers, and noncirrhotic livers. Noncirrhotic livers showed higher D* and f values, and lower D values than HCCs and metastases (P < 0.04). CONCLUSION: The D* and f values, in addition to the D value, may be useful for evaluating the nature of diffusion and flowing spins in hepatic lesions and hepatic parenchyma.
The tumor-seeking agent most widely used in positron emission tomography (PET) is 2-(18)F-fluorodeoxy-D-glucose (FDG). The clinical usefulness of FDG PET has already been proved in detecting, staging and restaging various kinds of malignant tumors, but nuclear medicine physicians suffer from a "diagnostic dilemma," in which a relatively high false positive ratio of FDG PET in diagnosing malignant tumors prevails. To increase more specific tumor uptake or more specific tumor characterization, numerous PET radiopharmaceuticals have been developed, and some of them are being tested in clinical trials. This review will briefly survey the tumor uptake mechanism and clinical significance of representative non-FDG PET radiopharmaceuticals used in clinical trials for patients with cancers.
BACKGROUND: In this study, we retrospectively assessed the performance of 18-F-fluorodeoxyglucose positron emission tomography (FDG-PET) compared with computed tomography (CT) and esophagography for assessing the response of advanced esophageal squamous cell carcinoma (SCC) to neoadjuvant chemoradiotherapy. METHODS: We studied 10 patients with thoracic esophageal SCC who received neoadjuvant chemoradiotherapy followed by surgery. Tumor response was assessed by CT, endoscopy, esophagography and FDG-PET before and after neoadjuvant treatment. RESULTS: Assessment of the rate of decrease in standardized uptake value (SUV) revealed a partial response (more than 50% decrease) in 5 (50%) of the patients, and assessment of length decrease of FDG uptake showed a partial response in 9 (90%) of the patients. Comparison of the histological response and the rate of decrease of various parameters revealed significant associations between histological response and tumor length (P <0.05), SUV after neoadjuvant therapy (P <0.05), and reduction in the extent of FDG uptake (P <0.01). However histological response was not significantly correlated with the rate of reduction of SUV, for both CT and esophagography. CONCLUSIONS: FDG-PET may be of considerable value for predicting the pathologic response of esophageal SCC to neoadjuvant therapy. Despite assessment of SUV before neoadjuvant therapy, low FDG uptake after therapy and reduction in the extent of FDG uptake may provide a reliable assessment of the response to therapy.
We evaluated whether apparent diffusion coefficient (ADC) value is more useful than signal intensity for differentiating endometrial cysts from other pelvic cysts. In an in vitro study, signal intensity and diffusion coefficients were measured in whole blood phantoms in which blood oxidation was gradually increased and concentration subsequently diluted. Although both signal intensity and diffusion value were largely affected by blood concentration, diffusion value was almost independent of blood oxidation and red blood cell lysis-related diminution of magnetic nonhomogeneity, both factors greatly affecting signal intensity on T1- and T2-weighted images. In an in vivo study, differentiation between endometrial and other pelvic cysts was attempted by means of ADC values and signal ratios of cysts to muscles on T1- and T2-weighted images (T1- and T2-ratios). Endometrial cysts tended to show lower T2-ratios, higher T1-ratios, and lower ADC values than other pelvic cysts (p < 0.001). However, ADC values were not correlated with T1- and T2-ratios (p < /0.15/). The ability of ADC value to discriminate between these two groups (discriminant rate, 91.4%) was higher than that of T2-ratio (71.4%) or T1-ratio (88.6%). If combined, ADC and T1-ratio (or T2-ratio) showed higher discriminant rate (94.3%) than the combination of T1- and T2 ratios (88.6%). ADC value might be useful for evaluating the blood concentration of a cystic lesion, because diffusion value is more closely related to blood concentration and almost independent of blood oxidation and red blood cell lysis that largely affect signal intensity.
RATIONALE AND OBJECTIVES: Two algorithms can be used to measure portal venous perfusion (PVP) with contrast material-enhanced single-level liver computed tomography. The "direct" and "indirect" algorithms use data from the portal vein and aorta, respectively. This study compared PVP values obtained with direct and with indirect algorithms in a series of patients. MATERIALS AND METHODS: Both techniques were applied in 27 patients with cirrhosis (14 men and 13 women; mean age, 56.1 years +/- 9.4) and 18 control patients (seven men and 11 women; 52.8 years +/- 12.3). A single section through the liver was scanned after intravenous injection of ioversol (40-mL bolus; 320 mg of iodine per milliliter). RESULTS: Both techniques showed reduced PVP in patients with cirrhosis (0.63 for direct and 0.17 for indirect method) compared with control patients (1.06 and 0.26, respectively), but only the direct method agreed with physiologic expectations based on animal and human studies. In separating cirrhotic and control patients, the area under the receiver operating characteristic curve was significantly greater for the direct method (0.91 vs 0.78; P = .03). CONCLUSION: Both direct and indirect methods are feasible and distinguish well between cirrhotic and control patients, but the direct method is more physiologic and is preferable if portal venous data are available.
RATIONALE AND OBJECTIVES: The authors developed software for creating quantitative maps of arterial and portal perfusion in the upper abdominal organs on personal computers. The image quality of these perfusion computed tomographic (CT) images was visually evaluated. MATERIALS AND METHODS: In 58 patients (38 men, 20 women; mean age, 63.9 years +/- 11.9; range, 22-85 years) with various diseases of the upper abdomen, 91 single-section dynamic CT studies were obtained. The data were transferred on-line to a personal computer, and quantitative maps of arterial and portal perfusion were created by means of the maximum-slope method. Perfusion CT images were reviewed by a radiologist and a radiation technologist, and image quality was rated according to a four-category scoring system (1 = good quality, 2 = moderate, 3 = poor, 4 = images could not be created). RESULTS: Arterial perfusion CT images could be created in 81 (89%) of 91 examinations, and 74 images (81%) were scored as 1 or 2. Portal perfusion CT images could be created in 60 (68%) of 88 examinations, in which a portal trunk was included in the section, and 33 of them (38%) were scored as 1 or 2. Patient motion during dynamic CT sequences resulted in poor image quality in seven arterial and 27 portal perfusion images. CONCLUSION: Perfusion CT can combine quantitative perfusion maps with good anatomic detail in one image, although patient movement frequently degrades image quality in portal perfusion CT.
AIM: To determine the impact of computed tomography (CT) on the diagnosis and treatment plan in patients with acute abdominal pain. MATERIALS AND METHODS: A prospective study was undertaken in 125 adult patients presenting with acute abdominal pain (74 men and 51 women; 40.2 +/- 19.3 years; range, 18-92). Changes in diagnosis, gain in percentage diagnostic certainty and changes of treatment plan of the surgeons in the emergency department before and after CT were evaluated. Pre- and post-CT diagnoses were compared with the final diagnoses. RESULTS: CT findings changed the initial diagnosis in 40 (32.0%) patients. The diagnostic certainty was 58.3 +/- 22.9% before CT, and its gain after CT was 21.9 +/- 18.5 points (P < 0.0001). Post-CT diagnoses were consistent with the final diagnosis in 116 patients (92.8%), while pre-CT diagnoses were correct in 89 patients (71.2%; P < 0.0001). Initial treatment plans were changed in 31 (24.8%) patients after CT. In 57 (45.6%) patients, CT information changed diagnoses and/or treatment plans. No significant differences were observed in the diagnosis, diagnostic certainty and treatment plan among four surgeons. CONCLUSION: Contrast-enhanced CT frequently changed the clinical diagnoses with increased diagnostic certainty and the initial treatment plans.
Explore the source record for details and available documents.
Accurate detection of head and neck cancer is crucial in patients' quality of life. The head and neck area consists of many complicated anatomical structures. Conventional imaging procedures such as CT and MRI provide much detailed information, but accurate estimation of the spread of cancer is still limited. Positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) is clinically useful in detecting head and neck cancer, providing accurate estimates of head and neck primary cancer especially in cases that are equivocal on CT and/or MRI. FDG-PET is able to show metastatic lymph nodes that may appear normal on CT and/or MRI. Further, whole body FDG-PET makes it possible to detect distant metastases. The clinical usefulness of FDG-PET in head and neck cancer is discussed in this review.
We evaluation basic characteristics of a compact type semiconductor gamma camera (eZ-SCOPE AN) of Cadmium Zinc Telluride (CdZnTe). This new compact gamma camera has 256 semiconductors representing the same number of pixels. Each semiconductor is 2 mm square and is located in 16 lines and rows on the surface of the detector. The specific performance characteristics were evaluated in the study referring to NEMA standards; intrinsic energy resolution, intrinsic count rate performance, integral uniformity, system planar sensitivity, system spatial resolusion, and noise to the neighboring pixels. The intrinsic energy resolution measured 5.7% as FWHM. The intrinsic count rete performance ranging from 17 kcps to 1,285 kcps was evaluated, but the highest intrinsic count rate was not observed. Twenty percents count loss was recognized at 1,021 kcps. The integral uniformity was 1.3% with high sensitivity collimator. The system planar sensitivity was 33,330 cpm/MBq with high resolution collimator and 766,767 cpm/MBq with high sensitivity collimator. The system spatial resolution (FWHM) was 2.0 mm and 2.2 mm when the distance between source and collimator was 0 cm and 3 cm respectively.
This paper presents and evaluates Picture Archiving and Communication System (PACS) and its interaction with the image fusion applications using positron emission tomography (PET), CT, and MRI, as well as some clinical applications of fusion images. A network connections between medium-sized PACS involving CT, MRI, SPECT, and PET were developed. Image registration and fusion was achieved in the PET's workstation by Advanced Visual System (AVS) software. Reconstructed datasets of CT, MRI, SPECT, and PET were transferred and archived in PACS servers. Series of anatomical images of CT and MRI were fused with metabolical images of PET with (18)F labeled fluoro-2-deoxy-D-glucose (FDG). Throughput rate of image data, as well as clinical applications of fusion images were evaluated and correlated with phantom studies. The average throughput rate of archiving and processing steps was 0.45 Mbps, 0.77 Mbps, respectively. Image fusion experiment using phantom and patients' data showed high accuracy in all directions. The combination of PACS and image fusion provided very useful clinical tools and made it quite easy to maximize the benefit from the diagnostic imaging.
Air embolism is a rare but potentially fatal complication of percutaneous needle biopsy of the lung. We report a case of cerebral air embolism which occurred during computed tomography (CT)-guided needle biopsy. Air entering the aorta is depicted on CT-fluoroscopy images of the procedure.
PURPOSE: To assess and compare the usefulness of (11)C-Choline-positron emission tomography (PET) with that of 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG)-PET for the differentiation between benign and malignant in various tumors. MATERIALS AND METHODS: We examined 38 consecutive patients with various tumors, including seven patients with brain tumors, two with oral cavity tumor, two with esophageal cancer, six with lung cancer, 11 with bone tumor, nine with soft tissue tumors, and one with myeloma. (11)C-Choline-PET and FDG-PET were performed from five minutes and 40 minutes, respectively, after injection of 275-455 MBq tracer. Tracer uptakes were evaluated by the standardized uptake value (SUV) and were analyzed in according to the pathologic data. RESULTS: (11)C-Choline uptake in malignancies (3.9 +/- 1.7, n=24) was significantly higher than that in benign lesions (1.7 +/- 1.2, n=14) (P < 0.0001). On the other hand, the FDG uptake in malignancies was 4.9 +/- 2.0 (n=24) and was also significantly larger than that in benign lesions 1.6 +/- 1.3 (n=14) (P < 0.0001). The (11)C-Choline uptake in all the lesions correlated with FDG uptake (r=0.658, P < 0.02, n=38). According to the receiver operating characteristic (ROC) analysis, the area under the ROC curve for (11)C-Choline-PET was 0.871, and with no significant difference compared to FDG-PET with the area of 0.929. CONCLUSIONS: This study demonstrated that (11)C-Choline-PET is similar to FDG-PET in differentiation between malignant and benign lesion in various tumors.
We present two cases, in which perfusion CT demonstrated diffusely increased arterial and decreased portal perfusion of the liver parenchyma around liver abscess and infectious bilomas. These cases suggested that perfusion CT may be useful for a quantitative analysis of perfusion changes in infectious hepatobiliary diseases with good anatomical detail.
The uptake of 2-[(18)F]-fluoro-2-deoxy-d-glucose (FDG) into shoulder muscles was studied in 11 patients with rotator cuff tears. FDG was injected under resting conditions, and cuff muscle exercises were performed followed by evaluation of the standardized uptake value (SUV) in shoulder muscles bilaterally. Analysis was performed with a subtracted SUV, obtained by subtracting the SUV of the muscle at rest from that after exercise. Fusion imaging studies involving FDG positron emission tomography (PET) and magnetic resonance imaging would provide a novel strategy with the potential of improving on the limited resolution of PET images. In this study this relatively new strategy revealed a similar decrease in the supraspinatus SUV in cases involving both complete and partial tears. The SUV in the infraspinatus and subscapularis also decreased, regardless of whether these muscles were intact or ruptured; the SUV in the deltoid remained basically unchanged. With the use of this exercise protocol, FDG PET might prove useful for objective evaluation of rotator cuff muscle activity.
Renal localization of radiolabeled antibody fragments presents a problem in targeted imaging and radiotherapy. We recently reported that Fab fragments labeled with 3'-[(131)I]iodohippuryl N(epsilon)-maleoyl-l-lysine (HML) demonstrated markedly low renal radioactivity levels from early postinjection in mice. Previous studies suggested that low renal radioactivity levels were attributable to cleavage of the glycyl-lysine sequence in HML by the action of renal brush border enzymes, followed by urinary excretion of the resulting m-iodohippuric acid. In this study, an in vitro system using brush border membrane vesicles (BBMVs) isolated from the rat kidney cortex was developed to estimate renal brush border enzyme(s)-mediated cleavage of the peptide linkage. Low molecular weight HML derivatives, 3'-[(125)I]iodohippuryl l-lysine (HL), 3'-[(125)I]iodohippuryl N(epsilon)-tert-butoxycarbonyl-l-lysine (HBL), and their d-amino acid counterparts, were synthesized and incubated in BBMVs. Both [(125)I]HL and [(125)I]HBL generated m-[(125)I]iodohippuric acid after incubation in BBMVs at 37 degrees C while the latter liberated significantly higher amounts of the metabolite. [(125)I]d-HL and [(125)I]d-HBL failed to release the metabolite under similar conditions. The liberation of m-[(125)I]iodohippric acid from [(125)I]HL was significantly facilitated or completely inhibited by the addition of an activator or an inhibitor for carboxypeptidase M. The release of m-[(125)I]iodohippuric acid from [(125)I]HBL increased by the addition of the activator, whereas the inhibitor partially inhibited the release of the metabolite from [(125)I]HBL. The BBMV-mediated release of m-[(125)I]iodohippuric acid from [(125)I]HBL was not impaired by the addition of inhibitors for neutral endopeptidase or renal dipeptidase. These findings showed that the glycyl-l-lysine sequence in HML would be recognized and cleaved by metalloenzymes and nonmetalloenzymes on the renal brush border even when iodine was incorporated into a benzene ring and the N(epsilon)-amine residue of lysine was chemically modified, which supported the hypothesis that low renal radioactivity levels of HML-conjugated Fab fragments would be attributed to the release of m-iodohippuric acid by renal brush border enzymes. This study suggested that this in vitro system using BBMVs would be useful to estimate radiolabeling reagents of antibody fragments or peptides designed to reduce renal radioactivity with a variety of radionuclides.